Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/59301
Type
ArticleCopyright
Restricted access
Embargo date
2099-12-31
Sustainable Development Goals
03 Saúde e Bem-EstarCollections
Metadata
Show full item record
OMICS IN THE STUDY OF THE MAJOR PARASITIC DISEASES MALARIA AND SCHISTOSOMIASIS
Affilliation
Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Laboratório de Malária. Belo Horizonte, MG, Brazil
Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Laboratório de Malária. Belo Horizonte, MG, Brazil
Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Laboratório de Malária. Belo Horizonte, MG, Brazil
Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Laboratório de Malária. Belo Horizonte, MG, Brazil
Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Laboratório de Malária. Belo Horizonte, MG, Brazil
Abstract
Genomic, transcriptomic, proteomic, and metabolomic projects exemplify the “omics” era, and have significantly expanded available data for biomedical research. Recently, next generation sequencing technologies have even more greatly expanded DNA and RNA information. The present challenge is mining this information to obtain meaningful data such as that identifying novel drug targets and vaccine candidates. Several bioinformatics tools and new technologies have been used to high-throughput identification of potential candidates. We illustrate the utilization of new strategies in the study of two major parasitic diseases: schistosomiasis and malaria.
Share